Sanofi India Overview

  • Year Founded
  • 1956

Year Founded

  • Status
  • Public

  • Employees
  • 1,104

Employees

  • Stock Symbol
  • 500674

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $35.12
  • (As of Friday Closing)

Sanofi India General Information

Description

Sanofi India Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It focuses on a range of therapeutic areas, including diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines, among others, and sells its products through independent distributors predominantly in India. The company's products are manufactured in different types of dosage forms, including tablets, capsules (hard and soft), Eye/Ear drops, ampoules, vials, creams, and ointments, and are marketed under different brand names such as Soframycin, Lantus, Cardace, Soliqua, Solian, Thyrogen, Telcite, Zolineg, etc. Geographically, the company generates a majority of its revenue from India, followed by Singapore, and Other markets.

Contact Information

Formerly Known As
Hoechst Fedco Pharma, Hoechst Pharmaceuticals, Aventis Pharma
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Sanofi House, CTS Number 117-B, L&T Business Park
  • Saki Vihar Road, Powai
  • Mumbai, Maharashtra 400072
  • India
+91 022
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Sanofi House, CTS Number 117-B, L&T Business Park
  • Saki Vihar Road, Powai
  • Mumbai, Maharashtra 400072
  • India
+91 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi India Stock Performance

As of 13-Nov-2026, Sanofi India’s stock price is $35.12. Its current market cap is $809M with 23M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$35.12 $35.05 $29.12 - $52.52 $809M 23M 2.36K $1.71

Sanofi India Financials Summary

As of 30-Sep-2026, Sanofi India has a trailing 12-month revenue of $196M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 696,015 1,017,205 1,615,176 2,174,034
Revenue 196,454 209,214 237,701 239,979
EBITDA 57,000 53,893 54,543 63,349
Net Income 39,312 37,485 49,417 73,014
Total Assets 139,780 187,884 205,414
Total Debt 0 1,983 2,250 2,276
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sanofi India Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi India‘s full profile, request access.

Request a free trial

Sanofi India Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanofi India Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi India‘s full profile, request access.

Request a free trial

Sanofi India Investments & Acquisitions (3)

Sanofi India’s most recent deal was a Seed Round with SiCureMi for . The deal was made on 22-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SiCureMi 22-Sep-2021 Seed Round Other Healthcare Technology Systems
Universal Medicare 01-Nov-2011 Merger/Acquisition Pharmaceuticals
Universal NutriScience 01-Jan-2011 Merger/Acquisition Pharmaceuticals
To view Sanofi India’s complete investments and acquisitions history, request access »

Sanofi India ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

27.64 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Sanofi India’s complete esg history, request access »

Sanofi India Exits (1)

Sanofi India’s most recent exit was on 01-Jan-2011 from Universal NutriScience. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Universal NutriScience 01-Jan-2011 Completed
To view Sanofi India’s complete exits history, request access »

Sanofi India FAQs

  • When was Sanofi India founded?

    Sanofi India was founded in 1956.

  • Where is Sanofi India headquartered?

    Sanofi India is headquartered in Mumbai, India.

  • What is the size of Sanofi India?

    Sanofi India has 1,104 total employees.

  • What industry is Sanofi India in?

    Sanofi India’s primary industry is Pharmaceuticals.

  • Is Sanofi India a private or public company?

    Sanofi India is a Public company.

  • What is Sanofi India’s stock symbol?

    The ticker symbol for Sanofi India is 500674.

  • What is the current stock price of Sanofi India?

    As of 13-Nov-2026 the stock price of Sanofi India is $35.12.

  • What is the current market cap of Sanofi India?

    The current market capitalization of Sanofi India is $809M.

  • What is Sanofi India’s current revenue?

    The trailing twelve month revenue for Sanofi India is $196M.

  • What is Sanofi India’s annual earnings per share (EPS)?

    Sanofi India’s EPS for 12 months was $1.71.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process